Gregory Knutson - 01 Apr 2020 Form 4 Insider Report for U.S. Stem Cell, Inc.

Role: Director
Signature: /s/ Gregory Knutson
Issuer symbol: USRM on OTC
Transactions as of: 01 Apr 2020
Net transactions value: +$375,939,826,970
Form type: 4
Filing time: 23 Jul 2021, 16:02:00 UTC
Next filing: 04 Mar 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	USRM	Common Stock	Other	$8,674	+1,445,647	+4.7%	$0.006000	32,251,149	01 Apr 2020	Held by NorthStar Biotech Group, LLC of which Gregory Knutson is Managing Director	F1
transaction	USRM	Common Stock	Other	$9,161	+2,035,820	+6.1%	$0.004500	35,286,969	05 Oct 2020	Held by NorthStar Biotech Group, LLC of which Gregory Knutson is Managing Director	F1
transaction	USRM	Common Stock	Other	$9,135	+187,575	+0.53%	$0.0487	35,474,544	02 Apr 2021	Held by NorthStar Biotech Group, LLC of which Gregory Knutson is Managing Director	F1
holding	USRM	Common Stock						1,675,000	01 Apr 2020	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	USRM	Convertible promissory Note (right to buy)	Award	$375,939,800,000	+3,759,398	+104%	$100000.00^*	7,384,398	17 Feb 2021	Common Stock	3,759,398	$0.0266	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Interest payment on outstanding debt.